Martin Bergmann

8.6k total citations · 2 hit papers
166 papers, 5.2k citations indexed

About

Martin Bergmann is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Reproductive Medicine. According to data from OpenAlex, Martin Bergmann has authored 166 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 45 papers in Cardiology and Cardiovascular Medicine and 44 papers in Reproductive Medicine. Recurrent topics in Martin Bergmann's work include Sperm and Testicular Function (43 papers), Atrial Fibrillation Management and Outcomes (27 papers) and Cardiac Arrhythmias and Treatments (23 papers). Martin Bergmann is often cited by papers focused on Sperm and Testicular Function (43 papers), Atrial Fibrillation Management and Outcomes (27 papers) and Cardiac Arrhythmias and Treatments (23 papers). Martin Bergmann collaborates with scholars based in Germany, United States and United Kingdom. Martin Bergmann's co-authors include Klaus Steger, Sabine Kliesch, Kenneth M. Steín, W. Weidner, Boris Schmidt, Lucas V.A. Boersma, Horst Sievert, Timothy R. Betts, Stephan Kische and Thomas Schmitz and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Martin Bergmann

163 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry

2016 360 citations Lucas V.A. Boersma, Boris Schmidt et al. European Heart Journal profile →
Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial

2017 284 citations Lucas V.A. Boersma, Hueseyin Ince et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Bergmann Germany	38	1.7k	1.7k	1.1k	966	579	166	5.2k
Hitoshi Sawada Japan	40	1.8k 1.0×	1.9k 1.1×	471 0.4×	452 0.5×	580 1.0×	261	5.6k
Henrik Fox Germany	36	2.1k 1.2×	1.1k 0.6×	308 0.3×	1000 1.0×	313 0.5×	269	7.5k
Georg J. Arnold Germany	39	1.7k 1.0×	454 0.3×	497 0.5×	649 0.7×	515 0.9×	153	4.0k
Patrick Shannon Canada	38	1.2k 0.7×	223 0.1×	1.1k 1.1×	675 0.7×	614 1.1×	155	5.0k
S. Lee Adamson Canada	43	1.7k 1.0×	690 0.4×	123 0.1×	532 0.6×	484 0.8×	139	6.0k
Norbert Hübner Germany	50	4.2k 2.4×	1.9k 1.1×	129 0.1×	843 0.9×	1.3k 2.2×	173	8.4k
Christoph Schmid Switzerland	53	3.2k 1.9×	1.0k 0.6×	115 0.1×	2.3k 2.4×	1.5k 2.5×	266	10.3k
Pietro M. Motta Italy	32	1.1k 0.6×	237 0.1×	1.2k 1.1×	503 0.5×	352 0.6×	137	3.6k
J. Beyer Germany	53	1.4k 0.8×	300 0.2×	982 0.9×	4.5k 4.7×	705 1.2×	407	9.3k
Matthias M. Weber Germany	39	1.1k 0.6×	289 0.2×	156 0.1×	1.1k 1.1×	543 0.9×	180	4.7k

Countries citing papers authored by Martin Bergmann

Since Specialization

Citations

This map shows the geographic impact of Martin Bergmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Bergmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Bergmann more than expected).

Fields of papers citing papers by Martin Bergmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Bergmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Bergmann. The network helps show where Martin Bergmann may publish in the future.

Co-authorship network of co-authors of Martin Bergmann

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Bergmann. A scholar is included among the top collaborators of Martin Bergmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Bergmann. Martin Bergmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ince, Hueseyin, Stephan Kische, Evgeny Pokushalov, et al.. (2024). Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trial. EP Europace. 26(7). 4 indexed citations

Garot, Philippe & Martin Bergmann. (2023). Limitations in Contemporary Pharmacological Stroke Prevention Therapies in Atrial Fibrillation: A Descriptive Literature Review. Journal of Clinical Medicine. 12(20). 6594–6594. 2 indexed citations

Bergmann, Martin, Barış Kılıçaslan, J. Bartunek, et al.. (2023). The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study. European Heart Journal. 44(Supplement_2). 2 indexed citations

Saw, Jacqueline, Jens Erik Nielsen‐Kudsk, Martin Bergmann, et al.. (2019). Antithrombotic Therapy and Device-Related Thrombosis Following Endovascular Left Atrial Appendage Closure. JACC: Cardiovascular Interventions. 12(11). 1067–1076. 69 indexed citations

Bergmann, Martin, Hüseyin İnce, Stephan Kische, et al.. (2018). Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study. EuroIntervention. 13(17). 2003–2011. 40 indexed citations

Klein, Britta, Hans‐Christian Schuppe, Martin Bergmann, et al.. (2017). An in vitro model demonstrates the potential of neoplastic human germ cells to influence the tumour microenvironment. Andrology. 5(4). 763–770. 14 indexed citations

Holmes, David R., Vivek Y. Reddy, Maurice Buchbinder, et al.. (2017). The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) trial. American Heart Journal. 189. 68–74. 67 indexed citations

Klein, Britta, Daniela Fietz, Sivanjah Indumathy, et al.. (2016). Specific immune cell and cytokine characteristics of human testicular germ cell neoplasia. Human Reproduction. 31(10). 2192–2202. 68 indexed citations

Verheye, Stefan, John A. Ormiston, Martin Bergmann, et al.. (2015). Twelve-month results of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShotª Ablation System (RAPID) study. EuroIntervention. 10(11). 1221–1229. 23 indexed citations

10.

Sánchez‐Guijo, Alberto, Bernhard Ugele, Michaela F. Hartmann, et al.. (2014). Transport of the placental estriol precursor 16α-hydroxy-dehydroepiandrosterone sulfate (16α-OH-DHEAS) by stably transfected OAT4-, SOAT-, and NTCP-HEK293 cells. The Journal of Steroid Biochemistry and Molecular Biology. 143. 259–265. 37 indexed citations

11.

Bergmann, Martin, Sven Haufe, Florian von Knobelsdorff‐Brenkenhoff, et al.. (2011). A Pilot Study of Chronic, Low-Dose Epoetin-β Following Percutaneous Coronary Intervention Suggests Safety, Feasibility, and Efficacy in Patients with Symptomatic Ischaemic Heart Failure. European Journal of Heart Failure. 13(5). 560–568. 16 indexed citations

12.

Azzouzi, Hamid el, Ralph J. van Oort, Roel van der Nagel, et al.. (2009). MEF2 Transcriptional Activity Maintains Mitochondrial Adaptation in Cardiac Pressure Overload. European Journal of Heart Failure. 12(1). 4–12. 22 indexed citations

13.

Zelarayán, Laura C., Claudia Noack, Belaïd Sekkali, et al.. (2008). β-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proceedings of the National Academy of Sciences. 105(50). 19762–19767. 104 indexed citations

14.

Herde, Katja, Sonja Hartmann, Ralph Brehm, et al.. (2007). Connexin 43 expression of foreign body giant cells after implantation of nanoparticulate hydroxyapatite. Biomaterials. 28(33). 4912–4921. 15 indexed citations

15.

Omisanjo, Olufunmilade, Katharina Biermann, Sonja Hartmann, et al.. (2006). DNMT1 and HDAC1 gene expression in impaired spermatogenesis and testicular cancer. Histochemistry and Cell Biology. 127(2). 175–181. 57 indexed citations

16.

Fischer, Petra, Ralph Brehm, Lutz Konrad, et al.. (2005). Connexin 33: A Rodent‐Specific Member of the Gap Junction Protein Family?. Journal of Andrology. 26(1). 75–84. 12 indexed citations

17.

Klonisch, Thomas, Klaus Steger, Astrid Kehlen, et al.. (2003). INSL3 Ligand-Receptor System in the Equine Testis1. Biology of Reproduction. 68(6). 1975–1981. 31 indexed citations

18.

Staples, Karl J., Martin Bergmann, Katsuyuki Tomita, et al.. (2001). Adenosine 3′,5′-Cyclic Monophosphate (cAMP)-Dependent Inhibition of IL-5 from Human T Lymphocytes Is Not Mediated by the cAMP-Dependent Protein Kinase A. The Journal of Immunology. 167(4). 2074–2080. 63 indexed citations

19.

Steger, Klaus, Frank Tetens, & Martin Bergmann. (1999). Expression of connexin 43 in human testis. Histochemistry and Cell Biology. 112(3). 215–220. 74 indexed citations

20.

Leifke, Eckhard, Manuela Simoni, Axel Kamischke, et al.. (1997). Does the gonadotrophic axis play a role in the pathogenesis of Sertoli‐cell‐only syndrome?. International Journal of Andrology. 20(1). 29–36. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact